Single-use Bioreactors Market
Single-use Bioreactors Market - Global Industry Assessment & Forecast
#
Pages:
132
2022
Mar - 2022
VMR-1351
Segments Covered
By
Product Single-use Bioreactor Systems, Single-use Media Bags, Single-use Filtration Assemblies, Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
-
By
Type Stirred-tank SUBs, Wave-induced SUBs, Bubble-column SUBs, Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
-
By
Type of Cell Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells (Insect and plant cells)
-
By
Molecule Type Monoclonal Antibodies, Vaccines, Gene-modified cells, Stem Cells, Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
-
By
Application Research and Development (R&D), Process Development, Bioproduction
-
By
End User Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4073.87 Million |
 Revenue 2030:
|
USD 18230.00 Million |
 Revenue CAGR
(2023 - 2030): |
20.60% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for Single-use Bioreactors in terms of revenue?
-
The global Single-use Bioreactors valued at USD 4073.87 Million in 2022 and is expected to reach USD 18230.00 Million in 2030 growing at a CAGR of 20.60%.
Which are the prominent players in the market?
-
The prominent players in the market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), CESCO Bioengineering (US), Cellexus (US), PBS Biotech Inc. (US), Distek Inc. (US), ABEC (US), Able Corporation & Biott Corporation (Japan), G&G Technologies Inc. (US), Solida Biotech GmBH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmBH (Germany), Celltainer Biotech BV (Netherlands), Meissner Filtration Products Inc. (US), bbi-biotech GmBH (Germany), ENDEL ENGIE (France), OmniBRx biotechnologies (India), New Horizon Biotechnology Inc. (US), GPC Bio (US), Cell culture company (US), and Aptus bioreactors (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 20.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Single-use Bioreactors include
- the variation in sub-nuclear and cell assessments
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Single-use Bioreactors in 2022.
